CAR T-Cell Therapy Update From ASH 2017 - 101868


CAR T-Cell Therapy Update From ASH 2017

Description: Chimeric antigen receptor (CAR) T-cell therapy has been receiving buzz as a promising treatment for cancer patients. So which CAR T-cell treatments are currently approved? Dr. David Maloney, Medical Director of the Bezos Family Immunotherapy Clinic at Seattle Cancer Care Alliance, joins Patient Power at the 2017 American Society of Hematology (ASH) meeting in Atlanta to explain. Dr. Maloney discusses how this approach works, the long-term durability of the treatment and progress in managing potential side effects.
Shared By : P2Professional
Posted on : 01/04/18
Added : 1 year ago
Category : News